Considering both Novera Retatrutide and Hyalgan Durolane target articular discomfort , their mechanisms of action are significantly contrasting. Novo Nordisk's Retatrutide is a dual agonist targeting the GLP-1 receptor and GIP , primarily used for metabolic regulation, which can secondarily less